embryonic stem cell lines

06/14/2012 - 10:00

Six new human embryonic stem cell lines derived at the University of Michigan have just been placed on the U.S. National Institutes of Health’s registry, making the cells available for federally-funded research. University of Michigan now has a total of eight cell lines on the registry, including five that carry genetic mutations for serious diseases such as the severe bleeding disorder hemophilia B, the fatal brain disorder Huntington’s disease and the heart condition called hypertrophic cardiomyopathy, which causes sudden death in athletes and others.